Callan Family Office’s Akoya BioSciences AKYA Stock Holding History

Callan Family Office’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,465	Closed	-$13.6K	–	852
2025 Q2	$13.6K	Buy	+10,465	New	+$12.6K	﹤0.01%	924

Callan Family Office's AKYA Position: Q3 2025 in Review

Callan Family Office sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 10,465 shares — an estimated $13.6K sold.

Callan Family Office first reported a position in AKYA in Q2 2025 and held it in 1 quarter. The position peaked at $13.6K in Q2 2025. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Callan Family Office reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Callan Family Office sold 10,465 Akoya BioSciences shares in Q3 2025, an estimated $13.6K.
Callan Family Office first reported a position in Akoya BioSciences in Q2 2025 and held it in 1 quarter.
Callan Family Office's Akoya BioSciences position peaked at $13.6K in Q2 2025.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Callan Family Office's 13F filing for Q3 2025, filed 4 Nov 2025.